From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for $0 million. With this, the company has completed the repurchase of 5,042,000 shares, representing 5.02% for $249.18 million under the buyback announced on March 12, 2020.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
65.61 USD | -0.46% | +0.75% | +23.12% |
05-29 | BTIG Adjusts Globus Medical's Price Target to $72 From $63, Keeps Buy Rating | MT |
05-20 | Piper Sandler Upgrades Globus Medical to Overweight From Neutral, Adjusts Price Target to $80 From $60 | MT |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+23.12% | 8.9B | |
-5.81% | 180B | |
-1.63% | 107B | |
-4.14% | 67.04B | |
+13.22% | 45.73B | |
-6.56% | 45.26B | |
+6.13% | 41.86B | |
+19.93% | 31.49B | |
+13.61% | 24.77B | |
-5.36% | 24.5B |
- Stock Market
- Equities
- GMED Stock
- News Globus Medical, Inc.
- Tranche Update on Globus Medical, Inc.'s Equity Buyback Plan announced on March 12, 2020.